Leavitt Chase C.
Insider CIK 1777467 · ONCT General Counsel/Secretary · MOBI See Remarks · BTX General Counsel/Secretary
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| MOBI Mobia Medical, Inc. | P Buy | 2026-09-11 | 2026-09-15 | 2,000 | $10.30 | $20.6K | 5,000 | SEC↗ |
| MOBI Mobia Medical, Inc. | P Buy | 2026-09-11 | 2026-09-15 | 2,000 | $10.30 | $20.6K | 5,000 | SEC↗ |
| MOBI Mobia Medical, Inc. | P Buy | 2026-05-11 | 2026-05-11 | 3,000 | $15.00 | $45.0K | 3,000 | SEC↗ |
| MOBI Mobia Medical, Inc. | A Award deriv | 2026-05-07 | 2026-05-11 | 175,760 | — | $0 | 175,760 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2024-02-14 | 2024-02-15 | 14,200 | — | $0 | 14,200 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2024-01-03 | 2024-01-05 | 11,838 | $0.50 | $5.9K | 84,758 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 55,519 | — | $0 | 55,519 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 65,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 235,000 | — | $0 | 235,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 55,519 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 65,000 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 28,750 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-10-02 | 2023-10-04 | 210,000 | — | $0 | 210,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | D To issuer deriv | 2023-10-02 | 2023-10-04 | 28,750 | — | $0 | 0 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-07-03 | 2023-07-05 | 10,305 | $0.36 | $3.7K | 96,596 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-13 | 2023-04-14 | 10,000 | $0.29 | $2.9K | 106,901 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2023-04-12 | 2023-04-14 | 15,000 | $0.29 | $4.3K | 96,901 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2023-02-21 | 2023-02-23 | 210,000 | — | $0 | 210,000 | SEC↗ |
| ONCT Oncternal Therapeutics, In | F Tax w/h | 2023-01-03 | 2023-01-05 | 6,091 | $1.02 | $6.2K | 81,901 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-07-28 | 2022-08-01 | 28,750 | — | $0 | 28,750 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-07-28 | 2022-08-01 | 43,125 | — | $0 | 87,992 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-01-28 | 2022-01-31 | 5,000 | $1.63 | $8.1K | 44,867 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2022-01-27 | 2022-01-31 | 8,500 | $1.78 | $15.1K | 39,867 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award deriv | 2022-01-20 | 2022-01-24 | 55,519 | — | $0 | 55,519 | SEC↗ |
| ONCT Oncternal Therapeutics, In | A Award | 2022-01-03 | 2022-01-05 | 29,867 | — | $0 | 31,367 | SEC↗ |
| ONCT Oncternal Therapeutics, In | P Buy | 2021-06-11 | 2021-06-15 | 1,500 | $5.45 | $8.2K | 1,500 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2021-03-15 | 2021-03-17 | 699,100 | — | $0 | 699,100 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2020-03-17 | 2020-03-19 | 616,700 | — | $0 | 616,700 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | P Buy | 2019-08-13 | 2019-08-15 | 5,000 | $1.02 | $5.1K | 5,000 | SEC↗ |
| LCTX Lineage Cell Therapeutics, | A Award deriv | 2019-07-31 | 2019-08-15 | 125,000 | — | $0 | 125,000 | SEC↗ |
| BTX BIOTIME INC | A Award deriv | 2019-05-20 | 2019-05-22 | 300,000 | — | $0 | 300,000 | SEC↗ |